Thrivent Financial for Lutherans’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,617	Closed	-$313K	–	2579
2024 Q3	$313K	Buy	+6,617	New	+$313K	﹤0.01%	2386
2022 Q2	–	Sell	-8,096	Closed	-$343K	–	2481
2022 Q1	$343K	Buy	+8,096	New	+$343K	﹤0.01%	2313